Paper Details

Paper Title

Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2023

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Melissa L Abel	Center for Cancer Research, National Cancer Institute
Yves Pommier	Center for Cancer Research, National Cancer Institute
Yves Pommier	Center for Cancer Research, National Cancer Institute
Mirit I Aladjem	Center for Cancer Research, National Cancer Institute
Mirit I Aladjem	Center for Cancer Research, National Cancer Institute
Mark Raffeld	Center for Cancer Research, National Cancer Institute
Mark Raffeld	Center for Cancer Research, National Cancer Institute

Column Actions